Quest Partners LLC Glaukos Corp Transaction History
Quest Partners LLC
- $1.53 Trillion
- Q3 2025
A detailed history of Quest Partners LLC transactions in Glaukos Corp stock. As of the latest transaction made, Quest Partners LLC holds 608 shares of GKOS stock, worth $54,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
608
Previous 644
5.59%
Holding current value
$54,738
Previous $66.5 Million
25.46%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
350Shares Held
55.4MCall Options Held
163KPut Options Held
458K-
Black Rock Inc. New York, NY8.04MShares$724 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.58MShares$322 Million0.05% of portfolio
-
Primecap Management CO Pasadena, CA2.25MShares$203 Million0.15% of portfolio
-
State Street Corp Boston, MA2.1MShares$189 Million0.01% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.29B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...